NVS

Novartis AG (NVS)

Last Price$109.41.9%
Market Cap$217.3B
LTM Operating Income margin
28.8%
5Y avg
20.9%
Drug Manufacturers - General industry median
20.3%
Stock quality & Intrinsic value
7/10
0.2% undervalued

Novartis AG Operating Income margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
NVS
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Operating Income margin
21.2%
21.6%
17.4%
21.1%
22.1%
22.4%
18.5%
20.0%
18.5%
20.7%
17.8%
16.7%
17.2%
15.4%
18.7%
20.3%
51.0%
17.7%
20.9%
28.1%
NVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NVS and see if it's the right time to invest.
Dive in

Novartis AG (NVS) Operating Income margin comparison analysis

Crunching data... Almost there!

NVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Novartis AG's Operating Income margin?

As of today, Microsoft Corp's last 12-month Operating Income margin is 28.8%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Operating Income margin for Novartis AG have been 21.6% over the past three years, and 21.9% over the past five years.

2) Is Novartis AG's Operating Income margin Good?

As of today, Novartis AG's Operating Income margin is 28.8%, which is higher than industry median of 20.3%. It indicates that Novartis AG's Operating Income margin is Good.

3) How does Novartis AG's Operating Income margin compare to its peers?

As of today, Novartis AG's Operating Income margin is 28.8%, which is higher than peer median of 20.3%. The list of peers includes LLY, MRK, GILD, PFE, AMGN, JNJ, AZN, BMY, SNY, ABBV.